Insider Transactions in Q1 2021 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
1,486
-4.85%
|
$93,618
$63.36 P/Share
|
|
Mar 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-3.13%
|
$38,367
$63.91 P/Share
|
|
Mar 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,025
+9.44%
|
-
|
|
Mar 10
2021
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,435
-4.95%
|
$90,405
$63.91 P/Share
|
|
Mar 10
2021
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,025
+9.45%
|
-
|
|
Mar 10
2021
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,123
-3.48%
|
$322,749
$63.91 P/Share
|
|
Mar 10
2021
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,800
+6.84%
|
-
|
|
Mar 10
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,107
-3.49%
|
$69,741
$63.91 P/Share
|
|
Mar 10
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,593
+7.55%
|
-
|
|
Mar 10
2021
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,639
-10.43%
|
$103,257
$63.91 P/Share
|
|
Mar 10
2021
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,455
+18.02%
|
-
|
|
Mar 10
2021
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,771
-4.83%
|
$111,573
$63.91 P/Share
|
|
Mar 10
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,794
+9.37%
|
-
|
|
Mar 01
2021
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,620
-15.3%
|
$1,526,440
$62.46 P/Share
|
|
Mar 01
2021
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,286
+14.45%
|
-
|
|
Feb 15
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
334
+1.13%
|
$18,704
$56.86 P/Share
|
|
Feb 15
2021
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
364
+2.88%
|
$20,384
$56.86 P/Share
|
|
Feb 15
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
364
+1.09%
|
$20,384
$56.86 P/Share
|
|
Feb 10
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
1,975
-6.41%
|
$132,325
$67.41 P/Share
|
|
Feb 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
197
-1.12%
|
$13,199
$67.29 P/Share
|
|
Feb 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
778
+4.23%
|
-
|
|
Feb 06
2021
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-1.63%
|
$36,584
$68.46 P/Share
|
|
Feb 06
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,818
+5.21%
|
-
|
|
Feb 06
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-2.39%
|
$51,204
$68.46 P/Share
|
|
Feb 06
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,728
+7.96%
|
-
|
|
Feb 06
2021
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-3.07%
|
$36,244
$68.46 P/Share
|
|
Feb 06
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,866
+9.71%
|
-
|
|
Feb 01
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
9,711
-25.2%
|
$631,215
$65.97 P/Share
|
|
Jan 28
2021
|
Sandra Horning Director |
BUY
Exercise of conversion of derivative security
|
Direct |
632
+50.0%
|
-
|
|
Jan 26
2021
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-2.73%
|
$57,948
$66.7 P/Share
|
|
Jan 26
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,855
+19.52%
|
-
|
|
Jan 26
2021
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
59,100
+35.65%
|
-
|
|
Jan 26
2021
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,214
+43.64%
|
-
|
|
Jan 26
2021
|
Johanna Mercier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,068
+23.7%
|
-
|
|
Jan 26
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,294
+7.71%
|
-
|
|
Jan 26
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,736
-8.84%
|
$246,576
$66.7 P/Share
|
|
Jan 26
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
27,635
+28.56%
|
-
|
|
Jan 22
2021
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,282
+21.47%
|
$405,640
$20.64 P/Share
|